News

Neurocrine Biosciences Plans Discussion on Financial Results

Neurocrine Biosciences Plans Discussion on Financial Results

Neurocrine Biosciences Plans Discussion on Financial Results

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a leader in the biopharmaceutical sector dedicated to neuroscience, has announced an important event for stakeholders. On February 6, 2025, the company will host a conference call and a webcast to disclose its financial results for the fourth quarter and year-end 2024. This is a significant occasion for the organization as it highlights their performance and future plans.

Event Schedule and Details

The financial results call is set for 1:30 p.m. Pacific Time, right after the release of the press statement which will occur at 1:00 p.m. PT. This timing allows analysts, investors, and interested parties to reflect on the detailed financial information before the call. Additionally, the conference call will provide a platform for discussions about the company’s strategic direction and upcoming projects.

Key Dates

Here’s an overview of the timeline for the event:

  • Press Release: February 6, 2025, at 1:00 p.m. PT
  • Conference Call: February 6, 2025, at 1:30 p.m. PT
  • Domestic Dial-In: 800-225-9448
  • International Dial-In: 203-518-9708
  • Conference ID: NBIX

Accessing the Webcast

The webcast will be readily available on Neurocrine Biosciences' official website, making it easy for all interested parties to participate. A replay will also be accessible approximately one hour following the live stream and will remain available for about a month, allowing individuals unable to join live to catch up on the valuable information shared.

About Neurocrine Biosciences

Neurocrine Biosciences is committed to addressing significant needs within the realm of neuroscience. The company focuses on the discovery and development of transformative treatments aimed at various neurological, neuroendocrine, and neuropsychiatric disorders. Their portfolio includes FDA-approved medications for conditions like tardive dyskinesia and chorea associated with Huntington's disease, showcasing their dedication to tackling complex medical issues.

Innovative Pipeline and Treatments

Bringing innovative solutions to the market, Neurocrine is actively developing a range of new treatments that promise to positively impact patients’ lives. Their diverse pipeline features several compounds that are currently in various stages of clinical development, reflecting their commitment to scientific progress and patient well-being.

Commitment to Patients

For over thirty years, Neurocrine has harnessed insights into the intricate workings of the brain and body to combat debilitating conditions. Their unwavering resolve to deliver effective treatments motivates their research and development efforts, aimed at easing the suffering of those affected by challenging disorders.

Frequently Asked Questions

What is Neurocrine Biosciences' upcoming event about?

Neurocrine Biosciences will host a conference call and webcast to discuss its fourth quarter and year-end financial results for 2024.

When will the event take place?

The event is scheduled for February 6, 2025, with a press release at 1:00 p.m. PT and the call at 1:30 p.m. PT.

How can I listen to the webcast?

The webcast will be available on the Neurocrine Biosciences website and will also have a replay for about a month after the live broadcast.

What is Neurocrine Biosciences known for?

Neurocrine is a biopharmaceutical company specializing in developing treatments for neurological and related conditions.

Where can I find more information about Neurocrine Biosciences?

For further details, visit Neurocrine Biosciences' official website or follow them on their social media platforms.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 9

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
Robotics in Cleaning: 2026 Sees Double Adoption Rates

Updated Category News Views 2

Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...

Continue Reading
WellLink Advisory Board Eyes Future of Healthcare Innovation

Updated Category News Views 2

Strategic Collaboration for Healthcare Evolution Ready to shake things up in healthcare, WellLink is setting the stage with its brand new Advisory Board. This move isn’t just about having fancy titles sitting around a conference table — it's about grabbing onto the future with both hands and figuring out just what the heck the healthcare industry needs next....

Continue Reading
NY Sheriffs' Court Battle: Immigration Policies Under Fire

Updated Category News Views 0

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

Continue Reading
G-STAR & Wu-Tang Clan Unleash Denim Fusion

Updated Category News Views 4

Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...

Continue Reading
Inovonics Duress Card Enhances Safety for K-12 and Beyond

Updated Category News Views 5

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Continue Reading
CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 4

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
TWP & Commbi Unveil Exclusive Pony Clog Collaboration

Updated Category News Views 4

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 6

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

Updated Category News Views 3

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Continue Reading

Top 5 Most Recently Viewed Articles

Genmab Streamlines Portfolio: Focus on Late-Stage Cancer Assets

Updated Category News Views 86

Genmab Enhances Focus on Promising Cancer Treatments Genmab A/S (NASDAQ: GMAB) has made a decisive move in its clinical strategy by announcing the discontinuation of further clinical development for acasunlimab. This decision represents a thoughtful pivot towards prioritizing late-stage assets that hold the most promise for future value creation. Strategic Rethink Amidst...

Continue Reading
NCLA's Legal Victory: Reversal of ATF's Bump-Stock Ban

Updated Category News Views 135

NCLA Achieves Legal Victory Over ATF's Bump-Stock Ban In an empowering turnaround, the New Civil Liberties Alliance (NCLA) has successfully persuaded the U.S. District Court to vacate the Bureau of Alcohol, Tobacco, Firearms and Explosives' (ATF) controversial ban on bump stocks. This landmark ruling marks a significant moment for civil liberties, affirming the rights of...

Continue Reading
Pacsun Unveils Team Tyson Collection for Upcoming Match

Updated Category News Views 97

Pacsun Launches Exclusive Team Tyson Merchandise Youth lifestyle retailer Pacsun is making waves in the fashion and sports arena with the launch of its latest collection called Team Tyson. This exclusive line gives fans and boxing enthusiasts a chance to grab exclusive merchandise at a special event designed to celebrate the upcoming match between Jake Paul and Mike...

Continue Reading
Albertsons Companies Inc. Reports Robust Q3 Results for 2024

Updated Category News Views 190

Albertsons Companies, Inc. Reports Strong Third Quarter Fiscal 2024 Results Albertsons Companies, Inc. (NYSE: ACI) announced its financial performance for the third quarter of fiscal 2024. This report highlights the company's profitability and growth strategies amidst a cautious consumer environment. Third Quarter Fiscal 2024 Highlights During this quarter, the company...

Continue Reading
India Faces Growing Trade Deficit Amid Gold Import Surge

Updated Category News Views 257

India's Trade Deficit Hits a New High Recent trade statistics from India reveal a troubling trend: the merchandise trade deficit has reached its highest point in ten months. In August, the deficit hit $29.65 billion, which has caught the attention of economists and analysts alike. This rise is primarily due to a sharp increase in gold imports, coupled with a decline in...

Continue Reading